Marie Deen

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Patient Reported

Cerebral Ischemia

Top Venues

Cephalalgia : an international journal of headache

The journal of headache and pain

This page only lists publications with an associated author ORCID identifier.

Publications

Katina Aleksovska, Andrew D Hershey, Marie Deen, Roberto De Icco, Mi Ji Lee, Hans-Christoph Diener
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society. Cephalalgia : an international journal of headache 43 (10) (2023)
Cristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, David W Dodick, Peter J Goadsby, Rigmor H Jensen, Delphine Magis, Patricia Pozo-Rosich, Hsiangkuo Yuan, Daniele Martinelli, Thomas van den Hoek, Marie Deen, Messoud Ashina, Gisela M Terwindt
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia : an international journal of headache 41 (11-12) (2021)
Marie Deen, Daniele Martinelli, Judith Pijpers, Hans-Christoph Diener, Stephen Silberstein, Michel D Ferrari, Messoud Ashina, Cristina Tassorelli, Hsiangkuo Yuan
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults. Cephalalgia : an international journal of headache 39 (8) (2019)
Marie Deen, Anders Hougaard, Hanne Demant Hansen, Claus Svarer, Hans Eiberg, Szabolcs Lehel, Gitte M Knudsen, Messoud Ashina
Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding. Cephalalgia : an international journal of headache 39 (4) (2018)
Marie Deen, Edvige Correnti, Katharina Kamm, Tim Kelderman, Laura Papetti, Eloisa Rubio-Beltrán, Simone Vigneri, Lars Edvinsson, Antoinette Maassen Van Den Brink, null null
Blocking CGRP in migraine patients - a review of pros and cons. The journal of headache and pain 18 (1) (2017)